Kolexia
Mainardi Jean-Luc
Médecine interne
Hôpital Européen Georges Pompidou
Paris, France
136 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Endocardite Endocardite bactérienne Infections à staphylocoques Tuberculose Maladies transmissibles Bactériémie Mucoviscidose Fibrose Sepsie

Industries

MSD
3 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Efficacy of single antibiotic therapy versus antibiotic combination in implant-free staphylococcal post-surgical spinal infections: a retrospective observational study.
BMC infectious diseases   08 janvier 2024
Prognosis of prosthetic valve infective endocarditis due to Streptococcus spp., a retrospective multi-site study to assess the impact of antibiotic treatment duration.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology   15 novembre 2023
Evaluating the heart valve tissue diffusion of amoxicillin in infective endocarditis: a pilot prospective observational non-comparative study.
The Journal of antimicrobial chemotherapy   25 octobre 2023
Diagnostic uncertainty in infectious diseases: Advocacy for a nosological framework
Infectious diseases now   01 septembre 2023
Characterization of Pseudomonas aeruginosa l,d-Transpeptidases and Evaluation of Their Role in Peptidoglycan Adaptation to Biofilm Growth.
Microbiology spectrum   31 mai 2023
Clinical and biological diagnosis and follow-up of patients treated for endovascular infections due to Coxiellaburnetii.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy   28 décembre 2022
BLUE-CarbA: BetaLACTA® Test-guided Early De-escalation of Empirical Carbapenems in Pulmonary, Urinary and Bloodstream Infections Diagnosed in Intensive Care Unit - BLUE¬-CarbA Study
Essai Clinique (Assistance publique – Hôpitaux de Paris)   16 décembre 2022
TIVAP-related infection due to Gram-negative aerobic bacilli: should TIVAP stay or should it go?
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology   06 décembre 2022
Modulation of the Specificity of Carbapenems and Diazabicyclooctanes for Selective Activity against Mycobacterium tuberculosis.
Antimicrobial agents and chemotherapy   09 août 2022
Impact of medical and pharmaceutical interventions on anti-infective prescriptions: an observational study.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology   25 juin 2022